IBS21.01 Enhanced Toxicity of IO with Concurrent Chemotherapy

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma

PURPOSE To evaluate the efficacy of IMRT combined with concurrent chemotherapy followed by adjuvant chemotherapy compared with IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma. METHODS From January 2007 to December 2014, we collected 797 staged II-IVb [UICC = Union for International Cancer Control criteria (7th edition)] NPC patients for analysis. Aft...

Chemotherapy Toxicity in Patients with Acute Leukemia

During the treatment for acute leukemia (AL) a patient may experience a wide variety of complications that mainly have three possible origins, namely the disease itself (leukemic infiltration), peripheral blood cell depression (because of hemorrhagic or infectious processes) and toxicity induced by chemotherapy. The toxicity of chemotherapy is a common cause of morbidity and mortality in cancer...

Concurrent write MPI/IO benchmarks on File Systems

In this report we tabulated and plotted concurrent I/O benchmarks on three different file systems namely a NAS, Panasas and Lustre file system. We ran the same executable on two file systems on one cluster because they were accessible on that cluster. The same code was recompiled and similar benchmark was ran on a remote cluster. We discuss the write I/O performance on the three different file ...

concurrent boost with adjuvant breast hypofractionated radiotherapy and toxicity assessment

background : the use of shorter radiotherapy schedules has an economic and logistic advantage for radiotherapy departments, as well as a high degree of patient convenience. the aim of this study is to assess the acute and short-term late toxicities of a hypofractionated radiotherapy schedule with a concomitant boost. methods : we enrolled 57 eligible patients as group a. these patients received...

Prolonged Vincristine Toxicity Induced by Concurrent Posaconazole in a Child with T-cell Acute Lymphoblastic Leukemia